Literature DB >> 21175915

Human growth hormone abuse in male weightlifters.

Brian P Brennan1, Gen Kanayama, James I Hudson, Harrison G Pope.   

Abstract

In a study of performance-enhancing substance use among 231 experienced young male weightlifters, we found that 27 (12%) reported illicit use of human growth hormone (HGH) or its bioactive derivative, insulin-like growth factor-1. All of these 27 men also reported use of anabolic-androgenic steroids (AAS) and 22 (81%) met criteria for current or past AAS dependence. Fifteen (56%) also reported current or past dependence on opioids, cocaine, and/or ecstasy. These findings suggest that among young male weightlifters, illicit HGH use has become a common form of substance abuse, frequently associated with both AAS dependence and classical substance dependence. American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21175915      PMCID: PMC3104052          DOI: 10.1111/j.1521-0391.2010.00093.x

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  32 in total

1.  Supraphysiological doses of GH induce rapid changes in cardiac morphology and function.

Authors:  Antonio Cittadini; Annika Berggren; Salvatore Longobardi; Christer Ehrnborg; Raffaele Napoli; Thord Rosén; Serafino Fazio; Kenneth Caidahl; Bengt-Ake Bengtsson; Luigi Saccà
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

Review 2.  Acromegaly and the cardiovascular system.

Authors:  Gaetano Lombardi; Mariano Galdiero; Renata S Auriemma; Rosario Pivonello; Annamaria Colao
Journal:  Neuroendocrinology       Date:  2006       Impact factor: 4.914

3.  Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels.

Authors:  Yutaka Matano; Toshihide Okada; Ayako Suzuki; Takashi Yoneda; Yoshiyun Takeda; Hiroshi Mabuchi
Journal:  Am J Gastroenterol       Date:  2005-05       Impact factor: 10.864

Review 4.  Effects of growth hormone on glucose and fat metabolism in human subjects.

Authors:  Jens O L Jørgensen; Louise Møller; Morten Krag; Nils Billestrup; Jens S Christiansen
Journal:  Endocrinol Metab Clin North Am       Date:  2007-03       Impact factor: 4.741

5.  Psychiatric and medical effects of anabolic-androgenic steroid use in women.

Authors:  A J Gruber; H G Pope
Journal:  Psychother Psychosom       Date:  2000       Impact factor: 17.659

6.  Steroid and prescription medicine abuse in the health and fitness community: A regional study.

Authors:  J S Baker; M R Graham; B Davies
Journal:  Eur J Intern Med       Date:  2006-11       Impact factor: 4.487

Review 7.  Physiological and pharmacological basis for the ergogenic effects of growth hormone in elite sports.

Authors:  Christer Ehrnborg; Thord Rosén
Journal:  Asian J Androl       Date:  2008-05       Impact factor: 3.285

8.  Potential benefits of recombinant human growth hormone (rhGH) to athletes.

Authors:  Michael R Graham; Julien S Baker; Peter Evans; David Hullin; Non-Eleri Thomas; Bruce Davies
Journal:  Growth Horm IGF Res       Date:  2009-06-17       Impact factor: 2.372

Review 9.  Anabolic steroid use: patterns of use and detection of doping.

Authors:  Michael R Graham; Bruce Davies; Fergal M Grace; Andrew Kicman; Julien S Baker
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

10.  Short-term recombinant human growth hormone administration improves respiratory function in abstinent anabolic-androgenic steroid users.

Authors:  Michael R Graham; Julien S Baker; Peter Evans; Andrew Kicman; David Cowan; David Hullin; Bruce Davies
Journal:  Growth Horm IGF Res       Date:  2007-05-23       Impact factor: 2.372

View more
  17 in total

1.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

2.  Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study.

Authors:  Harrison G Pope; Gen Kanayama; James I Hudson
Journal:  Biol Psychiatry       Date:  2011-08-12       Impact factor: 13.382

3.  Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.

Authors:  Miran Kondric; Damir Sekulic; Andrea Petroczi; Ljerka Ostojic; Jelena Rodek; Zdenko Ostojic
Journal:  Subst Abuse Treat Prev Policy       Date:  2011-10-11

Review 4.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

5.  Homicidality and Psychosis Caused by an Over-the-Counter Performance-Enhancing Supplement Containing Dendrobium Extract and L-Dopa.

Authors:  Alexandra Flynn; Jana Lincoln; Michael Burke
Journal:  P T       Date:  2016-06

6.  Performance-enhancing drugs on the web: a growing public-health issue.

Authors:  Brian P Brennan; Gen Kanayama; Harrison G Pope
Journal:  Am J Addict       Date:  2013-02-01

Review 7.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

Review 8.  Use of growth hormone, IGF-I, and insulin for anabolic purpose: Pharmacological basis, methods of detection, and adverse effects.

Authors:  Lindsey J Anderson; Jamie M Tamayose; Jose M Garcia
Journal:  Mol Cell Endocrinol       Date:  2017-06-09       Impact factor: 4.102

Review 9.  Nephrotoxic effects of common and emerging drugs of abuse.

Authors:  William F Pendergraft; Leal C Herlitz; Denyse Thornley-Brown; Mitchell Rosner; John L Niles
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-17       Impact factor: 8.237

10.  Identification of black market products and potential doping agents in Germany 2010-2013.

Authors:  Oliver Krug; Andreas Thomas; Katja Walpurgis; Thomas Piper; Gerd Sigmund; Wilhelm Schänzer; Tim Laussmann; Mario Thevis
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.